Biblio

Export 160 results:
[ Author(Desc)] Title Type Year
Filters: First Letter Of Last Name is G  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
G
F. T. Gossink, Dols, A., Krudop, W. A., Sikkes, S. A., Kerssens, C. J., Prins, N. D., Scheltens, P., Stek, M. L., and Pijnenburg, Y. A. L., “Formal Psychiatric Disorders are not Overrepresented in Behavioral Variant Frontotemporal Dementia.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1249-56, 2016.
M. L. Gosztyla, Brothers, H. M., and Robinson, S. R., “Alzheimer's Amyloid-β is an Antimicrobial Peptide: A Review of the Evidence.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1495-1506, 2018.
S. Goto, Shen, X., Sun, M., Hamano, Y., and Herrup, K., “The Positive Effects of Viewing Gardens for Persons with Dementia.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1705-1720, 2018.
D. Gouilly, Tisserand, C., Nogueira, L., Saint-Lary, L., Rousseau, V., Benaiteau, M., Rafiq, M., Carlier, J., Milongo-Rigal, E., Pagès, J. - C., and Pariente, J., “Taking the A Train? Limited Consistency of Aβ42 and the Aβ42/40 Ratio in the AT(N) Classification.”, J Alzheimers Dis, vol. 83, no. 3, pp. 1033-1038, 2021.
S. Gourmaud, Thomas, P., Thomasseau, S., Tible, M., Abadie, C., Paquet, C., and Hugon, J., “Brimapitide Reduced Neuronal Stress Markers and Cognitive Deficits in 5XFAD Transgenic Mice.”, J Alzheimers Dis, vol. 63, no. 2, pp. 665-674, 2018.
S. Gourmaud, Mouton-Liger, F., Abadie, C., Meurs, E. F., Paquet, C., and Hugon, J., “Dual Kinase Inhibition Affords Extended in vitro Neuroprotection in Amyloid-β Toxicity.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1659-1670, 2016.
J. Gräff, Rei, D., Guan, J. - S., Wang, W. - Y., Seo, J., Hennig, K. M., Nieland, T. J. F., Fass, D. M., Kao, P. F., Kahn, M., Su, S. C., Samiei, A., Joseph, N., Haggarty, S. J., Delalle, I., and Tsai, L. - H., “An epigenetic blockade of cognitive functions in the neurodegenerating brain.”, Nature, vol. 483, no. 7388, pp. 222-6, 2012.
M. S. Grames, Dayton, R. D., Lu, X., Schilke, R. M., J Alexander, S., A Orr, W., Barmada, S. J., Woolard, M. D., and Klein, R. L., “Gene Transfer Induced Hypercholesterolemia in Amyloid Mice.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1079-1086, 2018.
N. Gramunt, Sánchez-Benavides, G., Buschke, H., Diéguez-Vide, F., Peña-Casanova, J., Masramon, X., Fauria, K., Gispert, J. D., and Molinuevo, J. L., “The Memory Binding Test: Development of Two Alternate Forms into Spanish and Catalan.”, J Alzheimers Dis, vol. 52, no. 1, pp. 283-93, 2016.
N. Gramunt, Sánchez-Benavides, G., Buschke, H., Lipton, R. B., Masramon, X., Gispert, J. D., Peña-Casanova, J., Fauria, K., and Molinuevo, J. L., “Psychometric Properties of the Memory Binding Test: Test-Retest Reliability and Convergent Validity.”, J Alzheimers Dis, vol. 50, no. 4, pp. 999-1010, 2016.
G. Grande, Cucumo, V., Cova, I., Ghiretti, R., Maggiore, L., Lacorte, E., Galimberti, D., Scarpini, E., Clerici, F., Pomati, S., Vanacore, N., and Mariani, C., “Reversible Mild Cognitive Impairment: The Role of Comorbidities at Baseline Evaluation.”, J Alzheimers Dis, vol. 51, no. 1, pp. 57-67, 2016.
L. Grangeon, Paquet, C., Bombois, S., Quillard-Muraine, M., Martinaud, O., Bourre, B., Lefaucheur, R., Nicolas, G., Dumurgier, J., Gerardin, E., Jan, M., Laplanche, J. - L., Peoc'h, K., Hugon, J., Pasquier, F., Maltête, D., Hannequin, D., and Wallon, D., “Differential Diagnosis of Dementia with High Levels of Cerebrospinal Fluid Tau Protein.”, J Alzheimers Dis, vol. 51, no. 3, pp. 905-13, 2016.
M. W. Granger, Franko, B., Taylor, M. W., Messier, C., St George-Hyslop, P., and Bennett, S. A. L., “A TgCRND8 Mouse Model of Alzheimer's Disease Exhibits Sexual Dimorphisms in Behavioral Indices of Cognitive Reserve.”, J Alzheimers Dis, vol. 51, no. 3, pp. 757-73, 2016.
E. L. Granholm, Panizzon, M. S., Elman, J. A., Jak, A. J., Hauger, R. L., Bondi, M. W., Lyons, M. J., Franz, C. E., and Kremen, W. S., “Pupillary Responses as a Biomarker of Early Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1419-1428, 2017.
W. B. Grant and Blake, S. M., “Diet's Role in Modifying Risk of Alzheimer's Disease: History and Present Understanding.”, J Alzheimers Dis, vol. 96, no. 4, pp. 1353-1382, 2023.
M. Grassi, Perna, G., Caldirola, D., Schruers, K., Duara, R., and Loewenstein, D. A., “A Clinically-Translatable Machine Learning Algorithm for the Prediction of Alzheimer's Disease Conversion in Individuals with Mild and Premild Cognitive Impairment.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1555-1573, 2018.
P. Grau-Jurado, Mostafaei, S., Xu, H., Mo, M., Petek, B., Kalar, I., Naia, L., Kele, J., Maioli, S., Pereira, J. B., Eriksdotter, M., Chatterjee, S., and Garcia-Ptacek, S., “Medications and cognitive decline in Alzheimer's disease: Cohort cluster analysis of 15,428 patients.”, J Alzheimers Dis, p. 13872877241307870, 2025.
O. Grau-Rivera, Calvo, A., Bargalló, N., Monté, G. C., Nos, C., Lladó, A., Molinuevo, J. Luis, Gelpi, E., and Sánchez-Valle, R., “Quantitative Magnetic Resonance Abnormalities in Creutzfeldt-Jakob Disease and Fatal Insomnia.”, J Alzheimers Dis, vol. 55, no. 1, pp. 431-443, 2017.
N. E. Gray, Zweig, J. A., Kawamoto, C., Quinn, J. F., and Copenhaver, P. F., “STX, a Novel Membrane Estrogen Receptor Ligand, Protects Against Amyloid-β Toxicity.”, J Alzheimers Dis, vol. 51, no. 2, pp. 391-403, 2016.
S. L. Gray, Anderson, M. L., Hanlon, J. T., Dublin, S., Walker, R. L., Hubbard, R. A., Yu, O., Montine, T. J., Crane, P. K., Sonnen, J. A., C Keene, D., and Larson, E. B., “Exposure to Strong Anticholinergic Medications and Dementia-Related Neuropathology in a Community-Based Autopsy Cohort.”, J Alzheimers Dis, vol. 65, no. 2, pp. 607-616, 2018.
F. A. Greco, McKee, A. C., Kowall, N. W., and Hanlon, E. B., “Near-Infrared Optical Spectroscopy In Vivo Distinguishes Subjects with Alzheimer's Disease from Age-Matched Controls.”, J Alzheimers Dis, vol. 82, no. 2, pp. 791-802, 2021.
Z. D. Green, Vidoni, E. D., Swerdlow, R. H., Burns, J. M., Morris, J. K., and Honea, R. A., “Increased Functional Connectivity of the Precuneus in Individuals with a Family History of Alzheimer's Disease.”, J Alzheimers Dis, vol. 91, no. 2, pp. 559-571, 2022.
M. A. Gregory, Silva, N. C. Boa Sort, Gill, D. P., McGowan, C. L., Liu-Ambrose, T., J Shoemaker, K., Hachinski, V., Holmes, J., and Petrella, R. J., “Combined Dual-Task Gait Training and Aerobic Exercise to Improve Cognition, Mobility, and Vascular Health in Community-Dwelling Older Adults at Risk for Future Cognitive Decline1.”, J Alzheimers Dis, vol. 57, no. 3, pp. 747-763, 2017.
A. Griciuc, Serrano-Pozo, A., Parrado, A. R., Lesinski, A. N., Asselin, C. N., Mullin, K., Hooli, B., Choi, S. Hoon, Hyman, B. T., and Tanzi, R. E., “Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta.”, Neuron, vol. 78, no. 4, pp. 631-43, 2013.
C. M. Griffith, Macklin, L. N., Cai, Y., Sharp, A. A., Yan, X. - X., Reagan, L. P., Strader, A. D., Rose, G. M., and Patrylo, P. R., “Impaired Glucose Tolerance and Reduced Plasma Insulin Precede Decreased AKT Phosphorylation and GLUT3 Translocation in the Hippocampus of Old 3xTg-AD Mice.”, J Alzheimers Dis, vol. 68, no. 2, pp. 809-837, 2019.

Pages